We're looking forward to next week's Goldman Sachs Global Healthcare Conference, where our CEO, Roger M. Perlmutter, and CFO, Alfred (Freddie) Bowie, will be providing important business updates and highlighting the exciting progress of our lead clinical programs, along with key data presented at the recent #AACR24 and #ASCO24 meetings. To learn more and access an archived recording of the presentation, please visit: www.EikonTx.com/news. #TeamEikon #Biotech
Eikon Therapeutics’ Post
More Relevant Posts
-
We may have wrapped up #ALFC2024, but the insights were nothing short of transformative—and we've still got them on our minds. "Reflections on ALFC 2024: Key Takeaways and Future Directions" by Charlie Mamrak, DCN Dx's CEO, explores the pivotal role of lateral flow assays in shaping the future of global healthcare. From groundbreaking innovations to critical discussions on commercialization and funding, learn more about the key insights driving the #LFA industry forward. Check out the article here: https://hubs.ly/Q02pMXg_0 #LateralFlow #IVD #POCT #DiagnosticsInnovation #GlobalHealthcare
-
-
We may have wrapped up #ALFC2024, but the insights were nothing short of transformative—and we've still got them on our minds. "Reflections on ALFC 2024: Key Takeaways and Future Directions" by Charlie Mamrak, DCN Dx's CEO, explores the pivotal role of lateral flow assays in shaping the future of global healthcare. From groundbreaking innovations to critical discussions on commercialization and funding, learn more about the key insights driving the #LFA industry forward. Check out the article here: https://hubs.ly/Q02pN4TP0 #LateralFlow #IVD #POCT #DiagnosticsInnovation #GlobalHealthcare
-
-
Stay connected with Medtrade and the latest HME/DME industry news all year long! Subscribe to the #MedtradeMonday email newsletter today ➡️ https://bit.ly/4cEeCi6
-
-
Stay connected with Medtrade and the latest HME/DME industry news all year long! Subscribe to the #MedtradeMonday email newsletter today ➡️ https://bit.ly/4cEeCi6
-
-
We may have wrapped up #ALFC2024, but the insights were nothing short of transformative—and we've still got them on our minds. "Reflections on ALFC 2024: Key Takeaways and Future Directions" by Charlie Mamrak, DCN Dx's CEO, explores the pivotal role of lateral flow assays in shaping the future of global healthcare. From groundbreaking innovations to critical discussions on commercialization and funding, learn more about the key insights driving the #LFA industry forward. Check out the article here: https://hubs.ly/Q02pN2gj0 #LateralFlow #IVD #POCT #DiagnosticsInnovation #GlobalHealthcare
-
-
What a great recap of #ALFC from DCN Dx CEO Charlie Mamrak. I will quote a friend and colleague of mine that attended ALFC for the first time this year: “I thought I knew everything about lateral flow, but I was wrong.” This conference is all about the future and what we can do to make #pointofcare diagnostics better as well as find a way to get them to the other 50% of the population that doesn’t have access today. #ivd #rapidtesting #diagnostics #lateralflow
We may have wrapped up #ALFC2024, but the insights were nothing short of transformative—and we've still got them on our minds. "Reflections on ALFC 2024: Key Takeaways and Future Directions" by Charlie Mamrak, DCN Dx's CEO, explores the pivotal role of lateral flow assays in shaping the future of global healthcare. From groundbreaking innovations to critical discussions on commercialization and funding, learn more about the key insights driving the #LFA industry forward. Check out the article here: https://hubs.ly/Q02pN4TP0 #LateralFlow #IVD #POCT #DiagnosticsInnovation #GlobalHealthcare
-
-
In case you missed it: Last week, Ali, our CEO, caught up with Brad Loncar from BiotechTV to discuss all things ETX! During their conversation Ali delved into our innovative computational approach to development of GalOmic #RNAi therapies and discussed our experience of the dynamics of London’s capital markets. Watch the interview below! #AI #Biotech
𝐅𝐫𝐨𝐦 𝐋𝐨𝐧𝐝𝐨𝐧: e-therapeutics PLC's CEO Ali Mortazavi on the capital markets in London and his company's computational forward RNAi platform. He explains the decision to withdraw e-therapeutics from London AIM and describes the HepNet and GalOmic platforms that have produced the company's pipeline. Full video: https://lnkd.in/eTmGxkgD BiotechTV is brought to you by: Mispro | Breakthrough Properties | HSBC Innovation Banking | Theragent Inc | NYSE | Allucent
-
🚀 Join us & Ludovic d’Aprea, CEO Solution for Enterprise Imaging, GE HealthCare, at an exciting panel discussion at HLTH Europe in Amsterdam! 🗓️ 20 June 2024, 10:40 AM – 11:20 AM CEST / Aroma Stage 🎤 Topic: Goldmine or fool’s gold? Extracting value from health data Data has revolutionized industries from finance to retail. Healthcare data has the potential to transform our lives even more but remains underutilized, siloed, and mired in ethical debate. We need to move the conversation forward to unlock this potential. Where can data make the biggest impact in healthcare, and how do we access this goldmine? Don’t miss this discussion on transforming healthcare through data. See you there! #HealthData #GEHC #GEHealthCare #hltheurope
-
-
🚀 Join us & Ludovic d’Aprea, CEO Solution for Enterprise Imaging, GE HealthCare, at an exciting panel discussion at HLTH Europe in Amsterdam! 🗓️ 20 June 2024, 10:40 AM – 11:20 AM CEST / Aroma Stage 🎤 Topic: Goldmine or fool’s gold? Extracting value from health data Data has revolutionized industries from finance to retail. Healthcare data has the potential to transform our lives even more but remains underutilized, siloed, and mired in ethical debate. We need to move the conversation forward to unlock this potential. Where can data make the biggest impact in healthcare, and how do we access this goldmine? Don’t miss this discussion on transforming healthcare through data. See you there! #HealthData #GEHC #GEHealthCare #hltheurope
-
-
🚀 Join us & Ludovic d’Aprea, CEO Solution for Enterprise Imaging, GE HealthCare, at an exciting panel discussion at HLTH Europe in Amsterdam! 🗓️ 20 June 2024, 10:40 AM – 11:20 AM CEST / Aroma Stage 🎤 Topic: Goldmine or fool’s gold? Extracting value from health data Data has revolutionized industries from finance to retail. Healthcare data has the potential to transform our lives even more but remains underutilized, siloed, and mired in ethical debate. We need to move the conversation forward to unlock this potential. Where can data make the biggest impact in healthcare, and how do we access this goldmine? Don’t miss this discussion on transforming healthcare through data. See you there! #HealthData #GEHC #GEHealthCare #hltheurope
-
You can find a webcast of the presentation here on June 12th at 11:20am EDT: https://cc.webcasts.com/gold006/061024a_js/?entity=193_YDUD670